-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 24, Yuandong Biotechnology issued an announcement that the company recently received the "Drug Supplementary Application Approval Notice" for the chemical drug "Caffeine Citrate Injection" approved and issued by the State Food and Drug Administration, which is used for the treatment of preterm birth.
Caffeine citrate injection was approved in France on December 31, 1997 for the treatment of primary apnea in premature newborns.